Accordingly, miR-204 was identified as a tumour suppressor and a putative therapeutic agent, since in mouse xenograft experiments, MYCN-amplified cells transduced with an inducible miR-204 construct showed delayed tumourigenesis [28]. This evidence concerns the gene MYCN and neoplasm.